Impact of type 2 diabetes on clinical outcomes and advanced therapy use in patients with Crohn’s disease: a real-world propensity score-matched analysis
Patients with CD and coexisting T2DM experience a more severe disease course yet appear to be undertreated with advanced therapies. These findings highlight the need for tailored, multidisciplinary management strategies in this high-risk population.
Authors
- Vipul Jairath (ORCID: https://orcid.org/0000-0001-8603-898X)
- Sara Massironi (ORCID: https://orcid.org/0000-0003-3214-8192)
- Virginia Solitano (ORCID: https://orcid.org/0000-0002-2935-6778)
- Ferdinando D’Amico (ORCID: https://orcid.org/0000-0002-8591-6995)
- Laurent Peyrin‐Biroulet (ORCID: https://orcid.org/0000-0003-2536-6618)
- Federica Furfaro (ORCID: https://orcid.org/0000-0002-4308-7295)
- Mariangela Allocca (ORCID: https://orcid.org/0000-0002-7204-1739)
- Silvio Danese
Institutions
- Western University (CA)
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
- Université de Lorraine (FR)
Publication Details
- Journal
- Journal of Crohn s and Colitis
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1093/ecco-jcc/jjaf157
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00